GLOBAL BIOCHIPS MARKET FORECAST 2018-2026
KEY FINDINGS
The global biochips market is expected to grow considerably over the forecast years of 2018-2026. Factors like growing investments for R&D, government funding and increasing demand for personalized medicines is expected to lead to a 20.47% CAGR for this market by the end of 2026.
MARKET INSIGHTS
Segmentation of the global biochip market is done according to the substrates, types, and end users. The substrate segment of the market includes silicon, polymer, glass, and other substrates. The market segment by type includes protein chips, DNA chips, Lab on a chip, and others. The end-users for this market are hospitals and diagnostics centres, biotechnology and pharmaceutical companies, and academic and research institutes.
REGIONAL INSIGHTS
The geographical segmentation of the global biochips market is done into North America, Asia-Pacific, Europe and rest of world. The APAC biochips market is expected to rise with the highest CAGR over the forecast period, driven by countries like Japan, India, and China. On the other hand, the North American market dominated the global scene in 2017. Large-scale research projects in biosciences, coupled with the heavy investments by pharma and biotech companies for technological advancements are presenting lucrative opportunities to the North American market to expand further.
COMPETITIVE INSIGHTS
Major companies like Biochain Institute Inc, Agilent Technology Inc, Biomerieux SA, Cepheid Inc, Bio-Rad Laboratories Inc, Cybrdi Inc, Gamida For Life Group, Fluidigm Corporation, Illumina Inc, Merck Gmbh, Imgenex, Origene Technologies Inc, Samsung Electronics Inc, Perkinelmer Inc, and Thermo Fisher Scientific Inc are dealing in the global biochips market.
The global biochips market is expected to grow considerably over the forecast years of 2018-2026. Factors like growing investments for R&D, government funding and increasing demand for personalized medicines is expected to lead to a 20.47% CAGR for this market by the end of 2026.
MARKET INSIGHTS
Segmentation of the global biochip market is done according to the substrates, types, and end users. The substrate segment of the market includes silicon, polymer, glass, and other substrates. The market segment by type includes protein chips, DNA chips, Lab on a chip, and others. The end-users for this market are hospitals and diagnostics centres, biotechnology and pharmaceutical companies, and academic and research institutes.
REGIONAL INSIGHTS
The geographical segmentation of the global biochips market is done into North America, Asia-Pacific, Europe and rest of world. The APAC biochips market is expected to rise with the highest CAGR over the forecast period, driven by countries like Japan, India, and China. On the other hand, the North American market dominated the global scene in 2017. Large-scale research projects in biosciences, coupled with the heavy investments by pharma and biotech companies for technological advancements are presenting lucrative opportunities to the North American market to expand further.
COMPETITIVE INSIGHTS
Major companies like Biochain Institute Inc, Agilent Technology Inc, Biomerieux SA, Cepheid Inc, Bio-Rad Laboratories Inc, Cybrdi Inc, Gamida For Life Group, Fluidigm Corporation, Illumina Inc, Merck Gmbh, Imgenex, Origene Technologies Inc, Samsung Electronics Inc, Perkinelmer Inc, and Thermo Fisher Scientific Inc are dealing in the global biochips market.
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP-DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. NORTH AMERICA DOMINATES THE OVERALL BIOCHIPS MARKET
3.2.2. ASIA PACIFIC IS THE FASTEST EVOLVING REGIONAL MARKET
3.2.3. DNA CHIPS ACCOUNTS FOR THE LARGEST REVENUE SHARE OF BIOCHIPS MARKET BY TYPE SEGMENT
3.2.4. HOSPITALS & DIAGNOSTICS CENTERS – KEY END USER VERTICALS
3.2.5. PROTEIN CHIP IN THE TYPE SEGMENT IS PROJECTED TO RISE WITH THE HIGHEST GROWTH RATE
4. MARKET DYNAMICS
4.1. PARENT MARKET ANALYSIS: GENOMICS AND PROTEOMICS MARKET
4.2. ETYMOLOGY OF BIOCHIPS MARKET
4.3. MARKET DEFINITION & SCOPE
4.4. DRIVERS
4.4.1. INCREASING PREVALENCE OF CANCER
4.4.2. INCREASED GOVERNMENT FUNDING AND R&D INVESTMENT IN BIOTECHNOLOGY
4.4.3. GROWING INTEREST IN PERSONALIZED MEDICINES
4.4.4. SIGNIFICANT GROWTH IN THE HEALTHCARE EXPENDITURE ACROSS GEOGRAPHIES
4.5. RESTRAINTS
4.5.1. LACK OF HEALTHCARE COVERAGE
4.5.2. AVAILABILITY OF ALTERNATIVE TECHNOLOGY: NEXT GENERATION SEQUENCING (NGS) TECHNOLOGY
4.5.3. LACK OF AWARENESS ABOUT BIOCHIP TECHNOLOGY AMONGST THE MASSES
4.6. OPPORTUNITIES
4.6.1. TECHNOLOGICAL ADVANCEMENT IN BIOTECHNOLOGY
4.6.2. IMMENSE GROWTH OPPORTUNITIES IN SUB-CONTINENT OF ASIA
4.6.3. GROWING APPLICATIONS OF BIOCHIPS
4.7. CHALLENGES
4.7.1. COMPLEXITY OF BIOLOGICAL SYSTEMS
4.7.2. LACK OF COMMON REGULATORY STANDARDS
4.7.3. HIGH INSTRUMENTATION COST
5. MARKET BY TYPE
5.1. DNA CHIPS
5.1.1. AGRICULTURAL BIOTECHNOLOGY
5.1.2. CANCER DIAGNOSTICS & TREATMENT
5.1.3. DRUG DISCOVERY
5.1.4. GENE EXPRESSION
5.1.5. GENOMICS
5.1.6. SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
5.1.7. OTHER DNA CHIPS
5.2. LAB ON A CHIP
5.2.1. CLINICAL DIAGNOSTICS
5.2.2. DRUG DISCOVERY
5.2.3. GENOMICS
5.2.4. POINT OF CARE (POC) & IN VITRO DIAGNOSIS (IVS)
5.2.5. PROTEOMICS
5.2.6. OTHER LAB ON A CHIP
5.3. PROTEIN CHIPS
5.3.1. DIAGNOSTICS
5.3.2. DRUG DISCOVERY
5.3.3. EXPRESSION PROFILING
5.3.4. HIGH THROUGHPUT SCREENING
5.3.5. PROTEOMICS
5.3.6. OTHER PROTEIN CHIPS
5.4. OTHER CHIPS
5.4.1. CELL ARRAYS
5.4.2. TISSUE ARRAYS
6. MARKET BY SUBSTRATE MATERIALS
6.1. GLASS
6.2. POLYMERS
6.3. SILICON
6.4. OTHER SUBSTRATE MATERIALS
7. MARKET BY END USERS
7.1. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
7.2. HOSPITALS AND DIAGNOSTICS CENTERS
7.3. ACADEMIC AND RESEARCH INSTITUTE
8. KEY ANALYTICS
8.1. PORTER’S FIVE FORCE MODEL
8.1.1. THREAT OF NEW ENTRANTS
8.1.2. THREAT OF SUBSTITUTE
8.1.3. BARGAINING POWER OF SUPPLIERS
8.1.4. BARGAINING POWER OF BUYERS
8.1.5. THREAT OF COMPETITIVE RIVALRY
8.2. OPPORTUNITY MATRIX
8.3. VENDOR LANDSCAPE
8.4. VALUE CHAIN ANALYSIS
8.4.1. RESEARCH & DEVELOPMENT
8.4.2. RAW MATERIALS
8.4.3. MANUFACTURING
8.4.4. WHOLESALERS/RETAILERS/DISTRIBUTORS
8.4.5. END USERS
8.5. LEGAL, POLICY & REGULATORY FRAMEWORK
8.6. KEY BUYING CRITERIA
8.6.1. COST
8.6.2. APPLICATIONS
8.6.3. PRODUCT TYPE
8.7. INVESTMENT ANALYSIS
8.7.1. REGIONAL OPPORTUNITIES
8.7.2. OPPORTUNITIES BY END-USER SEGMENT
8.7.3. OPPORTUNITIES BY BIOCHIP TYPE SEGMENT
9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. UNITED STATES
9.1.2. CANADA
9.2. EUROPE
9.2.1. GERMANY
9.2.2. UNITED KINGDOM
9.2.3. FRANCE
9.2.4. ITALY
9.2.5. SPAIN
9.2.6. REST OF EUROPE
9.3. ASIA PACIFIC
9.3.1. CHINA
9.3.2. JAPAN
9.3.3. INDIA
9.3.4. SOUTH KOREA
9.3.5. AUSTRALIA
9.3.6. REST OF ASIA PACIFIC
9.4. REST OF WORLD
9.4.1. LATIN AMERICA
9.4.2. MIDDLE EAST AND AFRICA
10. COMPETITIVE LANDSCAPE
10.1. MARKET SHARE ANALYSIS
10.2. KEY COMPANY ANALYSIS
10.2.1. MERCK GMBH
10.2.2. AGILENT TECHNOLOGY INC.
10.2.3. ILLUMINA INC.
10.2.4. THERMO FISHER SCIENTIFIC INC.
10.3. CORPORATE STRATEGIES
10.3.1. PARTNERSHIP & COLLABORATION
10.3.2. MERGERS AND ACQUISITIONS
10.4. COMPANY PROFILES
10.4.1. AGILENT TECHNOLOGY INC.
10.4.2. BIOCHAIN INSTITUTE INC.
10.4.3. BIOMERIEUX SA
10.4.4. BIO-RAD LABORATORIES INC.
10.4.5. CEPHEID INC.
10.4.6. CYBRDI INC.
10.4.7. FLUIDIGM CORPORATION
10.4.8. GAMIDA FOR LIFE GROUP
10.4.9. ILLUMINA INC.
10.4.10. IMGENEX
10.4.11. MERCK GMBH
10.4.12. ORIGENE TECHNOLOGIES INC.
10.4.13. PERKINELMER INC.
10.4.14. SAMSUNG ELECTRONICS INC.
10.4.15. THERMO FISHER SCIENTIFIC INC
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP-DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. NORTH AMERICA DOMINATES THE OVERALL BIOCHIPS MARKET
3.2.2. ASIA PACIFIC IS THE FASTEST EVOLVING REGIONAL MARKET
3.2.3. DNA CHIPS ACCOUNTS FOR THE LARGEST REVENUE SHARE OF BIOCHIPS MARKET BY TYPE SEGMENT
3.2.4. HOSPITALS & DIAGNOSTICS CENTERS – KEY END USER VERTICALS
3.2.5. PROTEIN CHIP IN THE TYPE SEGMENT IS PROJECTED TO RISE WITH THE HIGHEST GROWTH RATE
4. MARKET DYNAMICS
4.1. PARENT MARKET ANALYSIS: GENOMICS AND PROTEOMICS MARKET
4.2. ETYMOLOGY OF BIOCHIPS MARKET
4.3. MARKET DEFINITION & SCOPE
4.4. DRIVERS
4.4.1. INCREASING PREVALENCE OF CANCER
4.4.2. INCREASED GOVERNMENT FUNDING AND R&D INVESTMENT IN BIOTECHNOLOGY
4.4.3. GROWING INTEREST IN PERSONALIZED MEDICINES
4.4.4. SIGNIFICANT GROWTH IN THE HEALTHCARE EXPENDITURE ACROSS GEOGRAPHIES
4.5. RESTRAINTS
4.5.1. LACK OF HEALTHCARE COVERAGE
4.5.2. AVAILABILITY OF ALTERNATIVE TECHNOLOGY: NEXT GENERATION SEQUENCING (NGS) TECHNOLOGY
4.5.3. LACK OF AWARENESS ABOUT BIOCHIP TECHNOLOGY AMONGST THE MASSES
4.6. OPPORTUNITIES
4.6.1. TECHNOLOGICAL ADVANCEMENT IN BIOTECHNOLOGY
4.6.2. IMMENSE GROWTH OPPORTUNITIES IN SUB-CONTINENT OF ASIA
4.6.3. GROWING APPLICATIONS OF BIOCHIPS
4.7. CHALLENGES
4.7.1. COMPLEXITY OF BIOLOGICAL SYSTEMS
4.7.2. LACK OF COMMON REGULATORY STANDARDS
4.7.3. HIGH INSTRUMENTATION COST
5. MARKET BY TYPE
5.1. DNA CHIPS
5.1.1. AGRICULTURAL BIOTECHNOLOGY
5.1.2. CANCER DIAGNOSTICS & TREATMENT
5.1.3. DRUG DISCOVERY
5.1.4. GENE EXPRESSION
5.1.5. GENOMICS
5.1.6. SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
5.1.7. OTHER DNA CHIPS
5.2. LAB ON A CHIP
5.2.1. CLINICAL DIAGNOSTICS
5.2.2. DRUG DISCOVERY
5.2.3. GENOMICS
5.2.4. POINT OF CARE (POC) & IN VITRO DIAGNOSIS (IVS)
5.2.5. PROTEOMICS
5.2.6. OTHER LAB ON A CHIP
5.3. PROTEIN CHIPS
5.3.1. DIAGNOSTICS
5.3.2. DRUG DISCOVERY
5.3.3. EXPRESSION PROFILING
5.3.4. HIGH THROUGHPUT SCREENING
5.3.5. PROTEOMICS
5.3.6. OTHER PROTEIN CHIPS
5.4. OTHER CHIPS
5.4.1. CELL ARRAYS
5.4.2. TISSUE ARRAYS
6. MARKET BY SUBSTRATE MATERIALS
6.1. GLASS
6.2. POLYMERS
6.3. SILICON
6.4. OTHER SUBSTRATE MATERIALS
7. MARKET BY END USERS
7.1. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
7.2. HOSPITALS AND DIAGNOSTICS CENTERS
7.3. ACADEMIC AND RESEARCH INSTITUTE
8. KEY ANALYTICS
8.1. PORTER’S FIVE FORCE MODEL
8.1.1. THREAT OF NEW ENTRANTS
8.1.2. THREAT OF SUBSTITUTE
8.1.3. BARGAINING POWER OF SUPPLIERS
8.1.4. BARGAINING POWER OF BUYERS
8.1.5. THREAT OF COMPETITIVE RIVALRY
8.2. OPPORTUNITY MATRIX
8.3. VENDOR LANDSCAPE
8.4. VALUE CHAIN ANALYSIS
8.4.1. RESEARCH & DEVELOPMENT
8.4.2. RAW MATERIALS
8.4.3. MANUFACTURING
8.4.4. WHOLESALERS/RETAILERS/DISTRIBUTORS
8.4.5. END USERS
8.5. LEGAL, POLICY & REGULATORY FRAMEWORK
8.6. KEY BUYING CRITERIA
8.6.1. COST
8.6.2. APPLICATIONS
8.6.3. PRODUCT TYPE
8.7. INVESTMENT ANALYSIS
8.7.1. REGIONAL OPPORTUNITIES
8.7.2. OPPORTUNITIES BY END-USER SEGMENT
8.7.3. OPPORTUNITIES BY BIOCHIP TYPE SEGMENT
9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. UNITED STATES
9.1.2. CANADA
9.2. EUROPE
9.2.1. GERMANY
9.2.2. UNITED KINGDOM
9.2.3. FRANCE
9.2.4. ITALY
9.2.5. SPAIN
9.2.6. REST OF EUROPE
9.3. ASIA PACIFIC
9.3.1. CHINA
9.3.2. JAPAN
9.3.3. INDIA
9.3.4. SOUTH KOREA
9.3.5. AUSTRALIA
9.3.6. REST OF ASIA PACIFIC
9.4. REST OF WORLD
9.4.1. LATIN AMERICA
9.4.2. MIDDLE EAST AND AFRICA
10. COMPETITIVE LANDSCAPE
10.1. MARKET SHARE ANALYSIS
10.2. KEY COMPANY ANALYSIS
10.2.1. MERCK GMBH
10.2.2. AGILENT TECHNOLOGY INC.
10.2.3. ILLUMINA INC.
10.2.4. THERMO FISHER SCIENTIFIC INC.
10.3. CORPORATE STRATEGIES
10.3.1. PARTNERSHIP & COLLABORATION
10.3.2. MERGERS AND ACQUISITIONS
10.4. COMPANY PROFILES
10.4.1. AGILENT TECHNOLOGY INC.
10.4.2. BIOCHAIN INSTITUTE INC.
10.4.3. BIOMERIEUX SA
10.4.4. BIO-RAD LABORATORIES INC.
10.4.5. CEPHEID INC.
10.4.6. CYBRDI INC.
10.4.7. FLUIDIGM CORPORATION
10.4.8. GAMIDA FOR LIFE GROUP
10.4.9. ILLUMINA INC.
10.4.10. IMGENEX
10.4.11. MERCK GMBH
10.4.12. ORIGENE TECHNOLOGIES INC.
10.4.13. PERKINELMER INC.
10.4.14. SAMSUNG ELECTRONICS INC.
10.4.15. THERMO FISHER SCIENTIFIC INC
LIST OF TABLES
TABLE 1: GLOBAL BIOCHIPS MARKET, BY GEOGRAPHY, 2018-2026 (IN $ MILLION)
TABLE 2: ESTIMATED NUMBER OF NEW CANCER CASES & ESTIMATED DEATHS DUE TO CANCER IN THE UNITED STATES (2017)
TABLE 3: NOTABLE INVESTMENTS MADE IN BIOTECHNOLOGY INDUSTRY IN 2017
TABLE 4: ESTIMATED R&D EXPENDITURE IN MEDICAL & HEALTHCARE INDUSTRY OF UNITED STATES, 2013-2015 (IN $ MILLIONS)
TABLE 5: ESTIMATED R&D SPENDING IN BIOTECHNOLOGY, PHARMACEUTICAL, & MEDICAL INDUSTRY OF UNITED STATES, 2013-2015 (IN $ MILLIONS)
TABLE 6: GLOBAL BIOCHIPS MARKET, BY TYPE, 2018-2026, (IN $ MILLION)
TABLE 7: GLOBAL DNA CHIPS MARKET, BY REGION, 2018-2026 (IN $ MILLION)
TABLE 8: GLOBAL DNA CHIPS MARKET, BY APPLICATIONS, 2018-2026 (IN $ MILLION)
TABLE 9: GLOBAL LAB ON A CHIP MARKET, BY REGION, 2018-2026 (IN $ MILLION)
TABLE 10: GLOBAL LAB ON A CHIP MARKET, BY APPLICATIONS, 2018-2026 (IN $ MILLION)
TABLE 11: GLOBAL PROTEIN CHIPS MARKET, BY REGION, 2018-2026 (IN $ MILLION)
TABLE 12: GLOBAL PROTEIN CHIPS MARKET, BY APPLICATIONS, 2018-2026 (IN $ MILLION)
TABLE 13: GLOBAL OTHER CHIPS MARKET, BY REGION, 2018-2026 (IN $ MILLION)
TABLE 14: GLOBAL OTHER CHIPS MARKET, BY APPLICATIONS, 2018-2026 (IN $ MILLION)
TABLE 15: GLOBAL BIOCHIPS MARKET, BY SUBSTRATE MATERIALS, 2018-2026 (IN $ MILLIONS)
TABLE 16: PROPERTIES OF BIOCHIPS SUBSTRATE MATERIALS
TABLE 17: GLOBAL GLASS MARKET, BY REGION, 2018-2026 (IN $ MILLIONS)
TABLE 18: GLOBAL POLYMERS MARKET, BY REGION, 2018-2026 (IN $ MILLIONS)
TABLE 19: GLOBAL SILICON MARKET, BY REGION, 2018-2026 (IN $ MILLIONS)
TABLE 20: GLOBAL OTHER SUBSTRATE MATERIALS MARKET, BY REGION, 2018-2026 (IN $ MILLIONS)
TABLE 21: GLOBAL BIOCHIPS MARKET, BY END USERS, 2018-2026 (IN $ MILLIONS)
TABLE 22: GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES MARKET, BY REGION, 2018-2026 (IN $ MILLIONS)
TABLE 23: GLOBAL HOSPITALS AND DIAGNOSTICS CENTERS MARKET, BY REGION, 2018-2026 (IN $ MILLIONS)
TABLE 24: GLOBAL ACADEMIC AND RESEARCH INSTITUTE MARKET, BY REGION, 2018-2026 (IN $ MILLIONS)
TABLE 25: OPPORTUNITY MATRIX FOR BIOCHIPS MARKET
TABLE 26: VENDOR LANDSCAPE OF BIOCHIPS MARKET
TABLE 27: LEGAL, POLICY & REGULATORY FRAMEWORK OF BIOCHIPS MARKET
TABLE 28: GLOBAL BIOCHIPS MARKET, BY GEOGRAPHY, 2018-2026, (IN $ MILLION)
TABLE 29: NORTH AMERICA BIOCHIPS MARKET, BY COUNTRY, 2018-2026 (IN $ MILLION)
TABLE 30: EUROPE BIOCHIPS MARKET, BY COUNTRY, 2018-2026 (IN $ MILLION)
TABLE 31: ASIA PACIFIC BIOCHIPS MARKET, BY COUNTRY, 2018-2026 (IN $ MILLION)
TABLE 32: REST OF WORLD BIOCHIPS MARKET, BY REGION, 2018-2026 (IN $ MILLION)
TABLE 33: LIST OF PARTNERSHIP & COLLABORATION
TABLE 34: LIST OF MERGERS AND ACQUISITIONS
TABLE 1: GLOBAL BIOCHIPS MARKET, BY GEOGRAPHY, 2018-2026 (IN $ MILLION)
TABLE 2: ESTIMATED NUMBER OF NEW CANCER CASES & ESTIMATED DEATHS DUE TO CANCER IN THE UNITED STATES (2017)
TABLE 3: NOTABLE INVESTMENTS MADE IN BIOTECHNOLOGY INDUSTRY IN 2017
TABLE 4: ESTIMATED R&D EXPENDITURE IN MEDICAL & HEALTHCARE INDUSTRY OF UNITED STATES, 2013-2015 (IN $ MILLIONS)
TABLE 5: ESTIMATED R&D SPENDING IN BIOTECHNOLOGY, PHARMACEUTICAL, & MEDICAL INDUSTRY OF UNITED STATES, 2013-2015 (IN $ MILLIONS)
TABLE 6: GLOBAL BIOCHIPS MARKET, BY TYPE, 2018-2026, (IN $ MILLION)
TABLE 7: GLOBAL DNA CHIPS MARKET, BY REGION, 2018-2026 (IN $ MILLION)
TABLE 8: GLOBAL DNA CHIPS MARKET, BY APPLICATIONS, 2018-2026 (IN $ MILLION)
TABLE 9: GLOBAL LAB ON A CHIP MARKET, BY REGION, 2018-2026 (IN $ MILLION)
TABLE 10: GLOBAL LAB ON A CHIP MARKET, BY APPLICATIONS, 2018-2026 (IN $ MILLION)
TABLE 11: GLOBAL PROTEIN CHIPS MARKET, BY REGION, 2018-2026 (IN $ MILLION)
TABLE 12: GLOBAL PROTEIN CHIPS MARKET, BY APPLICATIONS, 2018-2026 (IN $ MILLION)
TABLE 13: GLOBAL OTHER CHIPS MARKET, BY REGION, 2018-2026 (IN $ MILLION)
TABLE 14: GLOBAL OTHER CHIPS MARKET, BY APPLICATIONS, 2018-2026 (IN $ MILLION)
TABLE 15: GLOBAL BIOCHIPS MARKET, BY SUBSTRATE MATERIALS, 2018-2026 (IN $ MILLIONS)
TABLE 16: PROPERTIES OF BIOCHIPS SUBSTRATE MATERIALS
TABLE 17: GLOBAL GLASS MARKET, BY REGION, 2018-2026 (IN $ MILLIONS)
TABLE 18: GLOBAL POLYMERS MARKET, BY REGION, 2018-2026 (IN $ MILLIONS)
TABLE 19: GLOBAL SILICON MARKET, BY REGION, 2018-2026 (IN $ MILLIONS)
TABLE 20: GLOBAL OTHER SUBSTRATE MATERIALS MARKET, BY REGION, 2018-2026 (IN $ MILLIONS)
TABLE 21: GLOBAL BIOCHIPS MARKET, BY END USERS, 2018-2026 (IN $ MILLIONS)
TABLE 22: GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES MARKET, BY REGION, 2018-2026 (IN $ MILLIONS)
TABLE 23: GLOBAL HOSPITALS AND DIAGNOSTICS CENTERS MARKET, BY REGION, 2018-2026 (IN $ MILLIONS)
TABLE 24: GLOBAL ACADEMIC AND RESEARCH INSTITUTE MARKET, BY REGION, 2018-2026 (IN $ MILLIONS)
TABLE 25: OPPORTUNITY MATRIX FOR BIOCHIPS MARKET
TABLE 26: VENDOR LANDSCAPE OF BIOCHIPS MARKET
TABLE 27: LEGAL, POLICY & REGULATORY FRAMEWORK OF BIOCHIPS MARKET
TABLE 28: GLOBAL BIOCHIPS MARKET, BY GEOGRAPHY, 2018-2026, (IN $ MILLION)
TABLE 29: NORTH AMERICA BIOCHIPS MARKET, BY COUNTRY, 2018-2026 (IN $ MILLION)
TABLE 30: EUROPE BIOCHIPS MARKET, BY COUNTRY, 2018-2026 (IN $ MILLION)
TABLE 31: ASIA PACIFIC BIOCHIPS MARKET, BY COUNTRY, 2018-2026 (IN $ MILLION)
TABLE 32: REST OF WORLD BIOCHIPS MARKET, BY REGION, 2018-2026 (IN $ MILLION)
TABLE 33: LIST OF PARTNERSHIP & COLLABORATION
TABLE 34: LIST OF MERGERS AND ACQUISITIONS
LIST OF FIGURES
FIGURE 1: GLOBAL BIOCHIPS MARKET, BY END USERS, 2017 & 2026 (IN %)
FIGURE 2: NORTH AMERICA BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 3: ASIA PACIFIC BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 4: EVOLUTION & TRANSITION OF BIOCHIPS
FIGURE 5: WORLDWIDE HEALTHCARE SPENDING, BY REGIONS, 2014-2015 (% OF GDP)
FIGURE 6: UNITED STATES HEALTHCARE SPENDING, 2015-2025 (% OF GDP)
FIGURE 7: COMPARISON OF HEALTHCARE SPENDING PER CAPITA AND OUT OF THE POCKET HEALTH EXPENDITURE
FIGURE 8: GLOBAL BIOCHIPS MARKET, BY DNA CHIPS, 2018-2026 (IN $ MILLION)
FIGURE 9: GLOBAL DNA CHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2026 (IN $ MILLION)
FIGURE 10: GLOBAL DNA CHIPS MARKET, BY CANCER DIAGNOSTICS & TREATMENT, 2018-2026 (IN $ MILLION)
FIGURE 11: GLOBAL DNA CHIPS MARKET, BY DRUG DISCOVERY, 2018-2026 (IN $ MILLION)
FIGURE 12: GLOBAL DNA CHIPS MARKET, BY GENE EXPRESSION, 2018-2026 (IN $ MILLION)
FIGURE 13: GLOBAL DNA CHIPS MARKET, BY GENOMICS, 2018-2026 (IN $ MILLION)
FIGURE 14: GLOBAL DNA CHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2018-2026 (IN $ MILLION)
FIGURE 15: GLOBAL DNA CHIPS MARKET, BY OTHER CHIPS, 2018-2026 (IN $ MILLION)
FIGURE 16: GLOBAL BIOCHIPS MARKET, BY LAB ON A CHIP, 2018-2026 (IN $ MILLION)
FIGURE 17: GLOBAL LAB ON A CHIP MARKET, BY CLINICAL DIAGNOSTICS, 2018-2026 (IN $ MILLION)
FIGURE 18: GLOBAL LAB ON A CHIP MARKET, BY DRUG DISCOVERY, 2018-2026 (IN $ MILLION)
FIGURE 19: GLOBAL LAB ON A CHIP MARKET, BY GENOMICS, 2018-2026 (IN $ MILLION)
FIGURE 20: GLOBAL LAB ON A CHIP MARKET, BY POINT OF CARE (POC) & IN VITRO DIAGNOSIS (IVS), 2018-2026 (IN $ MILLION)
FIGURE 21: GLOBAL LAB ON A CHIP MARKET, BY PROTEOMICS, 2018-2026 (IN $ MILLION)
FIGURE 22: GLOBAL LAB ON A CHIP MARKET, BY OTHER LAB ON A CHIP, 2018-2026 (IN $ MILLION)
FIGURE 23: GLOBAL BIOCHIPS MARKET, BY PROTEIN CHIPS, 2018-2026 (IN $ MILLION)
FIGURE 24: GLOBAL PROTEIN CHIPS MARKET, BY DIAGNOSTICS, 2018-2026 (IN $ MILLION)
FIGURE 25: GLOBAL PROTEIN CHIPS MARKET, BY DRUG DISCOVERY, 2018-2026 (IN $ MILLION)
FIGURE 26: GLOBAL PROTEIN CHIPS MARKET, BY EXPRESSION PROFILING, 2018-2026 (IN $ MILLION)
FIGURE 27: GLOBAL PROTEIN CHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2018-2026 (IN $ MILLION)
FIGURE 28: GLOBAL PROTEIN CHIPS MARKET, BY PROTEOMICS, 2018-2026 (IN $ MILLION)
FIGURE 29: GLOBAL PROTEIN CHIPS MARKET, BY OTHER PROTEIN CHIPS, 2018-2026 (IN $ MILLION)
FIGURE 30: GLOBAL BIOCHIPS MARKET, BY OTHER CHIPS, 2018-2026 (IN $ MILLION)
FIGURE 31: GLOBAL OTHER BIOCHIPS MARKET, BY CELL ARRAYS, 2018-2026 (IN $ MILLION)
FIGURE 32: GLOBAL OTHER BIOCHIPS MARKET, BY TISSUE ARRAYS, 2018-2026 (IN $ MILLION)
FIGURE 33: GLOBAL BIOCHIPS MARKET, BY GLASS, 2018-2026 (IN $ MILLIONS)
FIGURE 34: GLOBAL BIOCHIPS MARKET, BY POLYMERS, 2018-2026 (IN $ MILLIONS)
FIGURE 35: GLOBAL BIOCHIPS MARKET, BY SILICON, 2018-2026 (IN $ MILLIONS)
FIGURE 36: GLOBAL BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2018-2026 (IN $ MILLIONS)
FIGURE 37: GLOBAL BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2018-2026 (IN $ MILLIONS)
FIGURE 38: GLOBAL BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2018-2026 (IN $ MILLIONS)
FIGURE 39: GLOBAL BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTE, 2018-2026 (IN $ MILLIONS)
FIGURE 40: PORTER’S FIVE FORCE MODEL OF BIOCHIPS MARKET
FIGURE 41: VALUE CHAIN OF BIOCHIPS MARKET
FIGURE 42: KEY IMPACT ANALYSIS
FIGURE 43: INVESTMENT OPPORTUNITIES IN BIOCHIPS MARKET, BY REGION
FIGURE 44: INVESTMENT OPPORTUNITIES IN BIOCHIPS MARKET, BY END-USER SEGMENT
FIGURE 45: INVESTMENT OPPORTUNITIES IN BIOCHIPS MARKET, BY TYPE SEGMENT
FIGURE 46: GLOBAL BIOCHIPS MARKET, REGIONAL OUTLOOK, 2017 & 2026 (IN %)
FIGURE 47: UNITED STATES BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 48: CANADA BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 49: GERMANY BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 50: UNITED KINGDOM BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 51: FRANCE BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 52: ITALY BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 53: SPAIN BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 54: REST OF EUROPE BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 55: CHINA BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 56: JAPAN BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 57: INDIA BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 58: SOUTH KOREA BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 59: AUSTRALIA BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 60: REST OF ASIA PACIFIC BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 61: LATIN AMERICA BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 62: MIDDLE EAST AND AFRICA BIOCHIPS MARKET, BY COUNTRY, 2018-2026 (IN $ MILLION)
FIGURE 63: MARKET SHARE ANALYSIS OF KEY PLAYERS IN 2017 (%)
COMPANIES MENTIONED
1. AGILENT TECHNOLOGY INC.
2. BIOCHAIN INSTITUTE INC.
3. BIOMERIEUX SA
4. BIO-RAD LABORATORIES INC.
5. CEPHEID INC.
6. CYBRDI INC.
7. FLUIDIGM CORPORATION
.8. GAMIDA FOR LIFE GROUP
9. ILLUMINA INC.
10. IMGENEX
11. MERCK GMBH
12. ORIGENE TECHNOLOGIES INC.
13. PERKINELMER INC.
14. SAMSUNG ELECTRONICS INC.
15. THERMO FISHER SCIENTIFIC INC
FIGURE 1: GLOBAL BIOCHIPS MARKET, BY END USERS, 2017 & 2026 (IN %)
FIGURE 2: NORTH AMERICA BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 3: ASIA PACIFIC BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 4: EVOLUTION & TRANSITION OF BIOCHIPS
FIGURE 5: WORLDWIDE HEALTHCARE SPENDING, BY REGIONS, 2014-2015 (% OF GDP)
FIGURE 6: UNITED STATES HEALTHCARE SPENDING, 2015-2025 (% OF GDP)
FIGURE 7: COMPARISON OF HEALTHCARE SPENDING PER CAPITA AND OUT OF THE POCKET HEALTH EXPENDITURE
FIGURE 8: GLOBAL BIOCHIPS MARKET, BY DNA CHIPS, 2018-2026 (IN $ MILLION)
FIGURE 9: GLOBAL DNA CHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2026 (IN $ MILLION)
FIGURE 10: GLOBAL DNA CHIPS MARKET, BY CANCER DIAGNOSTICS & TREATMENT, 2018-2026 (IN $ MILLION)
FIGURE 11: GLOBAL DNA CHIPS MARKET, BY DRUG DISCOVERY, 2018-2026 (IN $ MILLION)
FIGURE 12: GLOBAL DNA CHIPS MARKET, BY GENE EXPRESSION, 2018-2026 (IN $ MILLION)
FIGURE 13: GLOBAL DNA CHIPS MARKET, BY GENOMICS, 2018-2026 (IN $ MILLION)
FIGURE 14: GLOBAL DNA CHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2018-2026 (IN $ MILLION)
FIGURE 15: GLOBAL DNA CHIPS MARKET, BY OTHER CHIPS, 2018-2026 (IN $ MILLION)
FIGURE 16: GLOBAL BIOCHIPS MARKET, BY LAB ON A CHIP, 2018-2026 (IN $ MILLION)
FIGURE 17: GLOBAL LAB ON A CHIP MARKET, BY CLINICAL DIAGNOSTICS, 2018-2026 (IN $ MILLION)
FIGURE 18: GLOBAL LAB ON A CHIP MARKET, BY DRUG DISCOVERY, 2018-2026 (IN $ MILLION)
FIGURE 19: GLOBAL LAB ON A CHIP MARKET, BY GENOMICS, 2018-2026 (IN $ MILLION)
FIGURE 20: GLOBAL LAB ON A CHIP MARKET, BY POINT OF CARE (POC) & IN VITRO DIAGNOSIS (IVS), 2018-2026 (IN $ MILLION)
FIGURE 21: GLOBAL LAB ON A CHIP MARKET, BY PROTEOMICS, 2018-2026 (IN $ MILLION)
FIGURE 22: GLOBAL LAB ON A CHIP MARKET, BY OTHER LAB ON A CHIP, 2018-2026 (IN $ MILLION)
FIGURE 23: GLOBAL BIOCHIPS MARKET, BY PROTEIN CHIPS, 2018-2026 (IN $ MILLION)
FIGURE 24: GLOBAL PROTEIN CHIPS MARKET, BY DIAGNOSTICS, 2018-2026 (IN $ MILLION)
FIGURE 25: GLOBAL PROTEIN CHIPS MARKET, BY DRUG DISCOVERY, 2018-2026 (IN $ MILLION)
FIGURE 26: GLOBAL PROTEIN CHIPS MARKET, BY EXPRESSION PROFILING, 2018-2026 (IN $ MILLION)
FIGURE 27: GLOBAL PROTEIN CHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2018-2026 (IN $ MILLION)
FIGURE 28: GLOBAL PROTEIN CHIPS MARKET, BY PROTEOMICS, 2018-2026 (IN $ MILLION)
FIGURE 29: GLOBAL PROTEIN CHIPS MARKET, BY OTHER PROTEIN CHIPS, 2018-2026 (IN $ MILLION)
FIGURE 30: GLOBAL BIOCHIPS MARKET, BY OTHER CHIPS, 2018-2026 (IN $ MILLION)
FIGURE 31: GLOBAL OTHER BIOCHIPS MARKET, BY CELL ARRAYS, 2018-2026 (IN $ MILLION)
FIGURE 32: GLOBAL OTHER BIOCHIPS MARKET, BY TISSUE ARRAYS, 2018-2026 (IN $ MILLION)
FIGURE 33: GLOBAL BIOCHIPS MARKET, BY GLASS, 2018-2026 (IN $ MILLIONS)
FIGURE 34: GLOBAL BIOCHIPS MARKET, BY POLYMERS, 2018-2026 (IN $ MILLIONS)
FIGURE 35: GLOBAL BIOCHIPS MARKET, BY SILICON, 2018-2026 (IN $ MILLIONS)
FIGURE 36: GLOBAL BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2018-2026 (IN $ MILLIONS)
FIGURE 37: GLOBAL BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2018-2026 (IN $ MILLIONS)
FIGURE 38: GLOBAL BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2018-2026 (IN $ MILLIONS)
FIGURE 39: GLOBAL BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTE, 2018-2026 (IN $ MILLIONS)
FIGURE 40: PORTER’S FIVE FORCE MODEL OF BIOCHIPS MARKET
FIGURE 41: VALUE CHAIN OF BIOCHIPS MARKET
FIGURE 42: KEY IMPACT ANALYSIS
FIGURE 43: INVESTMENT OPPORTUNITIES IN BIOCHIPS MARKET, BY REGION
FIGURE 44: INVESTMENT OPPORTUNITIES IN BIOCHIPS MARKET, BY END-USER SEGMENT
FIGURE 45: INVESTMENT OPPORTUNITIES IN BIOCHIPS MARKET, BY TYPE SEGMENT
FIGURE 46: GLOBAL BIOCHIPS MARKET, REGIONAL OUTLOOK, 2017 & 2026 (IN %)
FIGURE 47: UNITED STATES BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 48: CANADA BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 49: GERMANY BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 50: UNITED KINGDOM BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 51: FRANCE BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 52: ITALY BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 53: SPAIN BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 54: REST OF EUROPE BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 55: CHINA BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 56: JAPAN BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 57: INDIA BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 58: SOUTH KOREA BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 59: AUSTRALIA BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 60: REST OF ASIA PACIFIC BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 61: LATIN AMERICA BIOCHIPS MARKET, 2018-2026 (IN $ MILLION)
FIGURE 62: MIDDLE EAST AND AFRICA BIOCHIPS MARKET, BY COUNTRY, 2018-2026 (IN $ MILLION)
FIGURE 63: MARKET SHARE ANALYSIS OF KEY PLAYERS IN 2017 (%)
COMPANIES MENTIONED
1. AGILENT TECHNOLOGY INC.
2. BIOCHAIN INSTITUTE INC.
3. BIOMERIEUX SA
4. BIO-RAD LABORATORIES INC.
5. CEPHEID INC.
6. CYBRDI INC.
7. FLUIDIGM CORPORATION
.8. GAMIDA FOR LIFE GROUP
9. ILLUMINA INC.
10. IMGENEX
11. MERCK GMBH
12. ORIGENE TECHNOLOGIES INC.
13. PERKINELMER INC.
14. SAMSUNG ELECTRONICS INC.
15. THERMO FISHER SCIENTIFIC INC
